235
Views
8
CrossRef citations to date
0
Altmetric
Research Article

Eosinophilic otitis media diagnosis using flow cytometric immunophenotyping

, , &
Pages 110-115 | Received 17 Jul 2017, Accepted 07 Sep 2017, Published online: 16 Oct 2017

References

  • Iino Y. Eosinophilic otitis media: a new middle ear disease entity. Curr Allergy Asthma Rep. 2008;8:525–530.
  • Nagamine H, Iino Y, Kojima C, et al. Clinical characteristics of so called eosinophilic otitis media. Auris Nasus Larynx. 2002;29:19–28.
  • Derlacki EL. Aural manifestations of allergy. Ann Otol Rhinol Laryngol. 1952;61:179–188.
  • Shambaugh G, Glasscock M, Glasscock ME. Surgery of the ear. 3rd ed. Philadelphia: WB Saunders; 1980.
  • Iino Y, Tomioka-Matsutani S, Matsubara A, et al. Diagnostic criteria of eosinophilic otitis media, a newly recognized middle ear disease. Auris Nasus Larynx. 2011;38:456–461.
  • Iino Y. Role of IgE in eosinophilic otitis media. Allergol Int. 2010;59:233–238.
  • Nishizawa H, Matsubara A, Nakagawa T, et al. The role of periostin in eosinophilic otitis media. Acta Otolaryngol. 2012;132:838–844.
  • Nonaka M, Fukumoto A, Ozu C, et al. IL-5 and eotaxin levels in middle ear effusion and blood from asthmatics with otitis media with effusion. Acta Otolaryngol. 2003;123:383–387.
  • Matsutani S, Kobayashi T, Takasaka T. Eosinophilic otitis media. Otolaryngol Head Neck Surg Tokyo. 1995;67:712–713.
  • Mengelers HJ, Maikoe T, Brinkman L, et al. Immunophenotyping of eosinophils recovered from blood and BAL of allergic asthmatics. Am J Respir Crit Care Med. 1994;149:345–351.
  • Gorczyca W, Sun Z-Y, Cronin W, et al. Immunophenotypic pattern of myeloid populations by flow cytometry analysis. Methods Cell Biol. 2011;103:221–266.
  • Davoine F, Labonte I, Ferland C, et al. Role and modulation of CD16 expression on eosinophils by cytokines and immune complexes. Int Arch Allergy Immunol. 2004;134:165–172.
  • Davoine F, Lavigne S, Chakir J, et al. Expression of FcgammaRIII (CD16) on human peripheral blood eosinophils increases in allergy conditions. J Allergy Clin Immunol. 2002;109:463–469.
  • Iino Y, Usubuchi H, Kodama K, et al. Bone conduction hearing level in patients with eosinophilic otitis media associated with bronchial asthma. Otol Neurotol off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2008;29:949–952.
  • Iino Y, Usubuchi H, Kodama K, et al. Eosinophilic inflammation in the middle ear induces deterioration of bone-conduction hearing level in patients with eosinophilic otitis media. Otol Neurotol off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2010;31:100–104.
  • Iino Y, Hara M, Hasegawa M, et al. Clinical efficacy of anti-IgE therapy for eosinophilic otitis media. Otol Neurotol Off Publ Am Otol Soc Am Neurotol Soc Eur Acad Otol Neurotol. 2012;33:1218–1224.
  • Okude A, Tagaya E, Kondo M, et al. A case of severe asthma with eosinophilic otitis media successfully treated with Anti-IgE monoclonal antibody omalizumab. Case Rep Pulmonol. 2012;2012:340525.
  • Wada T, Uemaetomari I, Murashita H, et al. Successful treatment of eosinophilic otitis media using ramatroban: report of two cases. Auris Nasus Larynx. 2006;33:455–460.
  • Iino Y, Nagamine H, Kakizaki K, et al. Effectiveness of instillation of triamcinolone acetonide into the middle ear for eosinophilic otitis media associated with bronchial asthma. Ann Allergy Asthma Immunol off Publ Am Coll Allergy Asthma Immunol. 2006;97:761–766.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.